Solana Company (formerly Helius Medical Technologies, Inc.), trading as HSDT on Nasdaq, filed an 8-K on November 3, 2025, announcing the release of new investor materials (Corporate Presentation/Investor Update and press release). While legally incorporated as a neurotech company, the firm is positioning itself primarily as an institutional Digital Asset Treasury (DAT) focused on acquiring and holding Solana (SOL).
The core strategy is to grow SOL per share (SPS) through capital markets activity, leveraging equity/debt issuance at a premium, and generating income via staking and DeFi yield, a
...